Role of Leptin and Ghrelin in Induction of Differentiation of IL-17-Producing and T-Regulatory Cells

被引:0
作者
E. G. Orlova
S. V. Shirshev
机构
[1] Ural Division of the Russian Academy of Sciences,Laboratory of Immunoregulation, Institute of Ecology and Genetics of Microorganisms
来源
Bulletin of Experimental Biology and Medicine | 2014年 / 156卷
关键词
leptin; ghrelin; T-regulatory cells; IL-17-producing cells; pregnancy;
D O I
暂无
中图分类号
学科分类号
摘要
We studied isolated and combined effects of leptin and ghrelin on the formation of ILproducing and T-regulatory cells. Leptin in concentrations comparable with its normal blood concentration during pregnancy (trimester II-III) promotes differentiation of peripheral blood CD4+ cells to IL-17-producing cells and enhances IL-17A production, but suppresses the formation of T-regulatory cells in vitro. In contrast, ghrelin in a concentration typical of trimester I-II of pregnancy reduces the number of IL-17-producing cells, but stimulated the formation of T-regulatory cells. The effects of leptin and ghrelin in combination typical of trimester I-II of pregnancy stimulated the formation of T-regulatory cells, while in combination typical of trimester II-III did not shift the balance of T-regulatory cells and IL-17-producing cells, but stimulated the formation of IL-17A. We conclude that leptin and ghrelin play an important role in the maintenance of the balance of IL-17-producing and T-regulatory cells during pregnancy.
引用
收藏
页码:819 / 822
页数:3
相关论文
共 43 条
  • [1] Shirshev SV(2011)undefined Dokl. Akad. Nauk 440 132-135
  • [2] Orlova EG(2007)undefined Nat. Immunol. 8 942-949
  • [3] Zamorina SA(2008)undefined J. Immunol. 20 1361-1368
  • [4] Nekrasova IV(2011)undefined Neuropharmacology 60 842-851
  • [5] Acosta-Rodriguez EV(2004)undefined J. Clin. Invest. 114 57-66
  • [6] Napolitani G(2005)undefined Clin. Endocrinol. 62 554-559
  • [7] Lanzavecchia A(1997)undefined Clin. Endocrinol. 47 101-106
  • [8] Sallusto F(2001)undefined J. Clin. Endocrinol. Metab. 86 4284-4291
  • [9] Annunziato F(2004)undefined Clin. Exp. Immunol. 136 373-378
  • [10] Cosmi L(2008)undefined J. Biol. Chem. 283 17,003-17,008